The addition of CD27 in Trop2-targeted CAR-T cells increased their antitumor effect in tumor cells and tumor-bearing mouse models by enhancing the expression of IL-7Rα and reducing the expression of PD-1 (25). Here, TACSTD2 is linked to neoplasm.